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phase Oamplitude (128.2 * 0.9 mV vs. 130.7 * 0.9 mV), notch amplitude
(56.1 + 2.2 mV vs. 54.1 + 1.9 mV), and plateau potential (19.3+ 1.0 mV vs.
20.9 + 1.0 mV). Action potential durations at 50% (APDW)and 90% (APDW)
repolarizatlon were significantly longer in gp 2 than in gp 1 at each cycle
length (p < 0.0018; see fig.).
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Ccmchisiar;Transient tachycardia superimposed on chronic bradycardia
lengthens depolarization in isolated canine ventricular myocytes, consistent
with electrical remodeling of ventricular myocerdium. Prolongation of action
potential duration Is correlated with dispersion of depolarization and with
development of afterdepciarizations that in turn may trigger arrhythmias.
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FibrillationbyRapidAtrialPacinginSheep
G.Tomassoni, L.M. Nicely, A. Natale, J.M. Wharton, P.D.Wolf. Duke
Univerai& Durham, NC, USA
Rapid atrial pacing has been shown tc create a substrate for atrial fibrillation
(AF) in dogs. However, its effects on sinus node function and atrial properties
in the larger sheep atria are unknown. Ten adult sheep (weight 112 * 13
Ibs) were paced using a right atrial (RA) transvenous lead and a modified
pacemaker (Mecftronic)at 400 bpm for =15 weeks. A baseline electrophys-
iologic study revealed no inducible episodes of sustained (>20 minutes) AF
by either programmed stimulation (S1S2S3S4) or burst pacing. Echocardio-
graphy revealed biatrial enlargement and normal left ventricular function in
all ten sheep. Biweekly helter monitoring in 6 sheep showed constant atrial
pacing with ventricular rates of 98 l 38 bpm. Three sheep developed per-
sistent atrial fibrillation during pacing. After 8 weeks, one out of 2 aheep had
inducible suatained atrial flutter (AFL). Sustainad inducible AF occurred in
6/8 cheep paced >10 weeks. Baeeline and post-pacing RA effective refrac-
tory period (ERP) at 300 and 400 ms ahorfened but not significantly (198 &
26 ms va 175 * 68 me, p = 0.3, 195 +=28 ms vs. 169 & 65 ms, p = 0.2,
respectively). In 6 cheep, AV nodal ERP at baeeline and after pacing were
233 +27 ms vs 246 =k29 ms (p = 0.08) while sinus node recovery time and
corrected einus node recovery time increaaed from 856 + 265 ms to 1365
+ 424 ms, p <0.003 and from 235 * 192 ms to 517 + 361 ms, p <0.03,
reapactively. Preliminary electron microscopy results reveal hyperfrophy of
the atrial cells compared to normals. Conclusions:1)Rapid atrial pacing =-10
weeke in cheep leads to biatrial enlargement, hypertrophy, and einua node
dysfunction resulting in a high incidence of sustained AF and 2) AF occurred
despite a minimal overall reduction in right atrial ERP.
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m7095 Regressionof LeftVentricularHypertrophyNormalizesActionPotentialDurationbyActivation
ofTransientOutwardCurrent
F.Tomita, T. Kohya, H. Yokoahiki, M. Kanno, A. Kitabatake. Hokkaido
University Sappcrc, Japan
Although the presence of left ventricular hypertrophy (LVH) has been as-
sociated with incraased of arrhythmias, it has not been elucidated whether
regression of LVHcan bear electrophyeiological benefit. We recently demon-
strated that regreaaionof LVHprevented ischemia-induced lethal arrhythmias
in spontaneously hypertensive rats (SHR) which showed prolongation of ac-
tion potential c!uration (APD). The aim of this study is to examine whether
regression of LVH can produce any changes in the ionic currents which may
be responsible for enhanced arrhythmogeneais in LVH. Hearts from SHR
were used as LVH and those from Wiater-Kyoto rats (WKY) served as con-
trol. SHR with regression of LVH (REG) was induced by 6-week captopril
treatment. Action potential and membrane currents of eubendccardial left
ventricular cells were compared by the patch clamp technique. Although
the membrane capacitance (pF) of SHR cella was significantly greater than
that of WKY celle, that of REG calls waa normalized to the control level.
Prolonged APD and reduced density of 4-aminopyridine-sensitive transient
outward current (ITCI ) in SHR was normalized by LVH regression. No sig-
nificant differences were observed in the densities of steady-state outward
current, inward rectifier current and L-type Ca2+ current. Regression of LVH
could normalize the proiongd APD in LVH by activation of ITOI,which may
becausely related to the reduced incidence ofarrhythmiaa in LVH regression.
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AtrlalRefractorinessandAtrialTachyarrhythmiasr
B.S. Stambler, R.K. Shepard, D.A. Turner, G. Fenelon, West Roxbuy VA
Medical Centq West RoxbuW,MA, USA, McGuire VAMedical Cente(
Richmond, VA, USA
Atrial arrhythmias are often associated with congestive heart failure (CHF) in
humans. The effects of chronic atrial dilatation on atrial refractoriness have
not been reported. Conscious dogs (n = 10) were etudied at baseline and
in CHF after 3-7 weeks of right ventricular pacing (200-250 bpm). Atrial
effective refractory period (ERP), dispersion of ERP (maximum-minimum)
and atrial conduction time (CT) were maasured at 3 cycle lengths (5oo, 400,
300ms) using3trensvenous, chronic atrial leads. Atrialarrhythmia inducibility
was studied by burst pacing and extrastimuli. During rapid ventricular pacing,
the mean atrial rate was 141 + 19 bpm and 1:1 ventriculoatrial conduction
was absent. In CHF, LVEF decreased (64 A 6 to 23 + 8%, p < 0.001) and
both atrial diameters increased (right: 25 & 3 to 36 l 6 mm; left: 30 + 3
to 39 + 4 mm, p c 0.001). Right atrial appendage, free wall and coronary
sinus ERPs prolonged (116 * 11to 136 * 15 ms at 500 ms, p < 0.001) in a
reverse use-dependent manner (+17%, +14%, +10% at 500, 400, 300 ins).
Autonomic blockade did not abolish the increaae in ERP during CHF. The
increase in ERP correlated with LVEF (r= 0.83, p = 0.01). Dispersion of ERP
(15 l 11 to 17+8 ms) and CT (61 + 19 to 56 &24 ms) did not change
significantly. At baseiine, atrial techycardia (AT) and fibrillation (AF) were
induced in 0/10 and 4/10 (93 + 4 ms) dogs, respectively. In CHF, suatained
(>30 reins) AT (119 * 9 ms) and AF (95•5 ms) were reproducibly induced
in W1O(p < 0.0007) and 9/10 (p= 0.06) dogs, respectively. Conclusion: This
CHF model has biatrlal dilatation, easiiy inducible AT and AF and in contrast
to atrial pacing models, reverse-use dependent prolongation of etrial ERP
without changes in dispersion or conduction times.
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\710-1I ca~edilolRedu~es~,in,~a,progre~,oninpatients
withModerate-SevereHeartFailure
W.S. Colucci, M. Packer, M.R. Briatow, M.B. Fowler, E.M.,Gilbert,
J.N. Cohn, S.T.Young, N.H. Shusterman for the Carvedilol Heart Failure
Study Group. Boston Medical Centec Boston, MA, USA
We previously reportedthat carvediloi (CRV) reduced the clinical progression
of heart failure (HF) in patients with mild (predominantly NYHA Ii) symptoma.
The U.S: Carvediiol Heart Failure Program randomized 1,094 NYHAclaaa 11-
P/ patients with LVEFs 0.35to placebo orCRV, in addition to ACE inhibitore,
for 6-12 months. To determine whether CRV also reduces clinical prcgree-
sicn in patients with moderate-aevere HF, we aeaeased clinical progression,
defined aa worsening HF leading to death, hospitalization or sustained in-
crease in HF medications, in patients with predominantly NYHA Ill and IV
symptoms enrolled in the moderate, dose-ranging and severe component
prctocols. Shown are the percent of patienta with clinical progre=ion in each
protoccl, and for comparison, the mild protocol:
Placebo CRV RR(95%Cl.) pvalue
Mild 25% 13”/0 0.50 (0.2S-0.78) 0.003
Moderate 35% 21”/0 0.61 (0.41-0.92) 0.018
Doe%-ranging 320/o 21”/0 0,67(0.45-1.002) 0.051
Severe 29”/o 11”/0 0.41 (0.15-1.06)
Overall
0.065
31”/0 18Y0 0,58 (0.48-0,74) <0,001
Conclusion: The addition of CRV to conventional therapy with an ACE
inhibitor reduces ciinical progression in patients with moderate-severe HF to
a degree similar to that seen in patients with mild symptoms.
